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Previous articles reported that beta-lactam antibiotics increase the expression of Staphylococcus aureus
Panton-Valentine leukocidin (PVL) by activating its transcription. We investigated the mechanisms underlying
the inductor effect of beta-lactams on PVL expression by determining targets and regulatory pathways possibly
implicated in this process. We measured PVL production in the presence of oxacillin (nonselective), imipenem
(penicillin-binding protein 1 [PBP1] selective), cefotaxime (PBP2 selective), cefaclore (PBP3 selective), and
cefoxitin (PBP4 selective). In vitro, we observed increased PVL production consistent with luk-PV mRNA levels
that were 20 to 25 times higher for community-acquired methicillin-resistant S. aureus (CA-MRSA) cultures
treated with PBP1-binding oxacillin and imipenem than for cultures treated with other beta-lactams or no
antibiotic at all. This effect was also observed in vivo, with increased PVL mRNA levels in lung tissues from
CA-MRSA-infected mice treated with imipenem but not cefoxitin. To confirm the involvement of PBP1
inhibition in this pathway, PBP1 depletion by use of an inducible pbp1 antisense RNA showed a dose-dependent
relationship between the level of pbp1 antisense RNA and the luk-PV mRNA level. Upon imipenem treatment
of exponential-phase cultures, we observed an increased sarA mRNA level after 30 min of incubation followed
by a decreased rot mRNA level after 1 to 4 h of incubation. Unlike the agr and saeRS positive regulators, which
were nonessential for PVL induction by beta-lactams, the sarA (positive) and rot (negative) PVL regulators
were necessary for PVL induction by imipenem. Our results suggest that antibiotics binding to PBP1 increase
PVL expression by modulating sarA and rot, which are essential mediators of the inductor effect of beta-lactams
on PVL expression.
Staphylococcus aureus is an important human pathogen
which expresses a variety of exoproteins, including the phage-
encoded Panton-Valentine leukocidin (PVL) (34, 65). The
prevalence of PVL in S. aureus isolates used to be low (ca. 2%)
but is currently increasing due to the worldwide diffusion of
PVL-producing methicillin-resistant S. aureus (MRSA) strains
(61). There has been a controversy on the pathogenic role of
PVL based on conflicting data from mouse infection models
(9, 37, 64), mainly due to subtle variations in different param-
eters of the model and to the low susceptibility of mice to PVL
(21, 62). However, recent studies with a rabbit pneumonia
model, which is more susceptible to PVL, confirmed the im-
portant role of this toxin in pathogenesis (20). Although PVL-
producing strains are isolated mainly from primary skin ab-
scesses, regardless of severity (3, 18), a strong epidemiological
link exists between PVL and severe infections, such as high-
mortality-rate necrotizing pneumonia and recurrent compli-
cated osteomyelitis (5, 22, 29, 30).
Although tightly linked to the phage genome and dependent
on it for horizontal transfer, most of the phage-encoded viru-
lence factors, including PVL, are integrated into the regulatory
mechanism of the host (8, 67). S. aureus virulence gene expres-
sion is regulated by specific factors clustered into complex
networks driving specific interactions with target gene promot-
ers. These factors are largely regulated by two-component reg-
ulatory systems sensitive to environmental signals, such as the
agr (47), autolysis-related locus arlRS (24), S. aureus exopro-
tein expression saeRS (31), and staphylococcal respiratory re-
sponse srrAB (69) systems. DNA-binding proteins, such as
SarA (13) and the recently identified SarA homologues SarR
(40), Rot (43), SarS (14, 59), SarT (56), and SarU (41), also
regulate virulence factor expression. The multiple pathways
generated by these factors allow the bacterium to adapt rapidly
and to promote growth under a large variety of environmental
conditions, which may also include the presence of antibiotics.
It was recently shown that subinhibitory concentrations of
beta-lactams increase PVL production in vitro via transcrip-
tional activation (23, 57), while agents that inhibit protein
synthesis, such as clindamycin and linezolid, reduce S. aureus
release of toxins, including PVL (4, 19, 23, 57). In spite of the
lack of in vivo data, but given that beta-lactam antibiotics may
lead to increased PVL production, some clinicians now recom-
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mend the avoidance of these agents possibly worsening the
clinical outcome of community-acquired MRSA (CA-MRSA)
infections (66). Nevertheless, little is known about the mech-
anisms underlying exoprotein modulation by antibiotics and
how antibiotics may interfere with the regulatory network con-
trolling virulence expression in S. aureus.
In this work, we studied the inductor effect of beta-lactams
on PVL expression in vitro and in vivo and investigated the
targets and regulatory pathways possibly implicated in PVL
modulation by beta-lactam antibiotics.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains, plasmids, and phages used in this study are
summarized in Table 1.
Antibiotics and MIC determination. Antibiotics used in this study were oxa-
cillin, cefaclore, and cefoxitin, purchased from Sigma-Aldrich (L’Isle d’Abeau,
France); imipenem, purchased from MSD Laboratories (Paris, France); and
cefotaxime, purchased from Dakota Pharm (Creteil, France). MICs were deter-
mined by broth microdilution assay as recommended by CLSI standards (15).
Bacterial cultures. Strains were cultured on Trypticase blood agar plates and
incubated overnight at 37°C. Isolated colonies were resuspended in distilled
water and adjusted to a 0.5 McFarland standard (corresponding to 108 CFU/ml,
as confirmed by bacterial counts), and 50 l of this suspension was inoculated
into 5 ml CCY broth contained in glass tubes. Cultures were performed at 37°C
with gyratory shaking (300 rpm) in the absence (growth control) and presence of
different antibiotics at 1/4 the MIC. When needed for selection, erythromycin
(Sigma) was used at a final concentration of 5 g/ml, and chloramphenicol
(Sigma) and kanamycin (Sigma) were used at 20 g/ml.
For expression studies of various regulators, cultures without antibiotics were
performed as described above and monitored by optical density at 600 nm
(OD600); when the OD600 reached 0.5, imipenem was added to the culture at a
concentration corresponding to 1/2 the MIC, and cultures were reincubated at
37°C with gyratory shaking (300 rpm). Aliquots were taken after 30 min and
hourly, and cellular pellets were prepared as described below for total RNA
extraction.
PVL quantification. At different times, aliquots of cultures were adjusted to an
OD600 of 1 and then centrifuged at 13,000  g for 10 min. PVL in the superna-
tant was quantified by a specific enzyme-linked immunosorbent assay (ELISA;
bioMe´rieux R&D Department, Marcy-l’Etoile, France) as described else-
where (2).
Relative qRT-PCR. Aliquots of 1 ml of each culture were centrifuged at
13,000  g, and pellets were washed with 1 ml of 10 mM Tris buffer and adjusted
to an OD600 of 1, corresponding to approximately 1 109 S. aureus cells/ml. One
milliliter of adjusted and washed bacterial suspension was centrifuged at
13,000  g, and pellets were treated with lysostaphin (Sigma) at a final concen-
tration of 200 g/ml. The total RNA of the pellets was then purified using a
Qiagen RNeasy Plus minikit according to the manufacturer’s instructions. The
amount of RNA yielded was assessed with a NanoDrop spectrophotometer, and
1 g of total RNA was reverse transcribed using a Promega reverse transcription
(RT) system with random primers as recommended by the provider. The result-
ing cDNA was used as a template for real-time amplification (LightCycler 2.0
Roche), using the specific primers shown in Table 2. The relative amounts of
amplicons specific for each gene were determined by quantitative PCR (qPCR)
relative to an internal standard (gyrB) as described elsewhere (37). The expres-
sion levels of investigated genes were expressed as n-fold differences relative to
TABLE 1. Strains, plasmids, and phage used in this study
Strain, plasmid,
or phage Reference or source Description
Strains
8325-4 46 NCTC8325 cured of three prophages
RN4220 35 Restriction mutant of 8325-4
RN6390 49 Laboratory strain (derivative of 8325-4) that maintains its hemolytic
activity on sheep erythrocyte agar
LUG855 37 RN6390 phiSLT
LUG856 This work RN6390 agr::tetM (47) phiSLT
LUG1160 This work RN6390 rot::cat
LUG1162 This work LUG1160 phiSLT
LUG1677 This work LUG1162 carrying pLUG895
LUG1053 This work RN6390 (12) phiSLT
LUG1063 This work ALC488 (RN6390 sarA::ermC) (12) phiSLT
LUG1619 This work ALC488 complemented with one sarA copy (41), with phiSLT
LUG1436 This work ISP479C (38) phiSLT
LUG1437 This work ISP479C-29 saeRS::kan (26) phiSLT
LUG1477 This work LUG855 carrying pLUG792
LUG1485 This work LUG855 carrying pLUG795
HT20010734 23 ST1; agr3 mecA pvl
HT20020488 23 ST80; agr3 mecA pvl
HT20030203 23 ST8; agr1 mecA pvl
HT20041010 23 ST80; agr3 mecA pvl
LAC USA300 64 ST8; agr1 mecA pvl
Plasmids
pC194 33 High-copy-number plasmid harboring cat gene
pMad 1 Thermosensitive origin of replication, constitutively expressed galB gene
pLUG641 This work pMad derivative for deletion/replacement of S. aureus rot gene
pLUG792 This work Derivative of pCN37 (11) carrying pbpA2567-2303 Cd-inducible
antisense RNA and pvl terminator
pLUG795 This work Derivative of pCN37 (11) carrying pvl terminator
pLUG895 This work Derivative of pTCvlac (53) lacking lacZ and ermB and carrying a 1.26-
kb fragment carrying rot
Phage
phiSLT 45 pvl-containing phage isolated from strain A980470
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the calibrator, calculated with RealQuant software (Roche Diagnostics).
Changes in mRNA levels were interpreted as significant if the variation was
2-fold.
qPCR. Aliquots of 1 ml of strain LUG855 cultured with and without beta-
lactams at 1/4 the MIC were centrifuged at 13,000  g, and pellets were washed
with 1 ml of 10 mM Tris buffer. Genomic DNA was isolated from the pellets by
using a Qiagen QIAmp DNA minikit as recommended by the provider. A
decimal dilution of the DNA yielded was used as a template for real-time pvl and
gyrB PCRs using specific primers (Table 2). Relative quantification of the pvl
gene copy number was assessed after normalization to the gyrB copy number.
Results are expressed as n-fold variations of the pvl/gyrB copy number in the
presence of antibiotics relative to the pvl/gyrB copy number of the growth control.
Quantification of the attP insertion site of phiSLT phage was performed by
quantitative real-time PCR with specific primers ISPVL1 and ISPVL2 (Table 2)
as described by Wirtz et al. (67).
Pbp1 antisense sequence construction. We amplified a 265-bp fragment of the
pbp1 gene by using the primers pbpA2303 (ATGGATCCTTAACTATGCCTG
ACATG), containing a BamHI restriction site (bold and underlined), and
pbpA2567 (ACTAGGCCTTGTCAGTTTTACTGTC), containing a StuI restric-
tion site. The fragment was digested with the BamHI and StuI restriction en-
zymes and ligated with the luk-PV transcriptional terminator (amplified using
primers phi2648 and phi2815 [60]). The ligation product was then used as a
template for PCR amplification using the pbpA2567 and phi2815 primers. After
being verified by sequencing, the fragment was ligated into the pGEM-T Easy
vector system (Promega). The resulting plasmid, pLUG789, was digested with
EcoRI and StuI, and the digestion product was ligated with pCN37 (11) digested
with EcoRI and SmaI. The ligation product, pLUG792 (see Fig. 4A), was then
transformed and cloned into Escherichia coli DH5 before successive electro-
poration (Bio-Rad gene pulser) into S. aureus RN4220 and LUG855. The ex-
pression of the pbp1 antisense sequence was assayed by RT-PCR with primers
pbp1R and pbp1phi (Table 2), the latter of which was designed to encompass the
3 end of the pbp1 antisense sequence and the 5 end of the luk-PV transcrip-
tional terminator. The control plasmid pLUG795, identical to pLUG792 but
lacking the pbp1 2567-2303 fragment, was obtained by successive BamHI diges-
tion and ligation of pLUG792.
RN6390 rot::cat construction. The rot::cat deletion/replacement mutant of S.
aureus RN6390 (LUG 1160) was obtained by using pMAD, a thermosensitive
plasmid which contains a constitutively expressed -galactosidase gene that al-
lows for positive selection of double-crossover mutants by screening the -ga-
lactosidase activity on an X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyrano-
side) agar plate (1). A 1,036-bp DNA fragment corresponding to the
chloramphenicol acetyltransferase gene was amplified from pC194 plasmid (33)
and cloned into pMAD between two DNA fragments, corresponding to the
640-bp 5-flanking region of the rot gene generated using primers rot824 (CAA
GTCGACTATATCGTGACTTAGTTGAAG [containing a SalI restriction site])
and rot1464 (CTTATCGATAAAACTACAAGTGTAAATAAACTTGC [con-
taining a ClaI restriction site]) and the 581-bp 3-flanking region of the rot gene
generated using primers rot1951 (GTGAAGCTTTAATAGCATAAAAAGAGG
TTTTC [containing a HindIII restriction site]) and rot2532 (ATTGATATCCG
AACAAGTACCAGAA [containing an EcoRV restriction site]). The resulting
plasmid, pLUG641, was successively electroporated into RN4220 and RN6390.
Transformants were grown at the nonpermissive temperature (37°C) to select for
cells in which the plasmid had been integrated into the chromosome by homol-
ogous recombination. To favor the second recombination event, a single colony
was grown at 30°C for 10 generations and plated at 37°C overnight. Cells which
had lost the plasmid vector through a double-crossover event were detected on
X-Gal agar plates. PCR amplifications were used to confirm the loss of the rot
gene, which was replaced by the cat gene.
Complementation of the mutated strain was performed with the pLUG895 plas-
mid containing a 1.26-kb fragment carrying rot which was obtained after EcoRI
digestion of the fragment generated by the amplification of the rot gene with the
EcoRI restriction site-containing primers TTGAATTCGTATATCACATTTTATA
CACATTTG and CGAGAATTCAAGCTATTAATTCATTGCTATC.
Visualization of the effect of pbp1 antisense sequence on cell structure. The
localization of new cell wall synthesis in strains LUG1477 and LUG1485 was
done as previously described (52). Briefly, cells were grown for 18 h in brain heart
infusion (BHI) with 5 M CdCl2 and 0.125 M D-serine to promote the incorpo-
ration of this amino acid into the cell wall. The culture was diluted 1/250 in the
same medium, grown to an OD600 of 0.6, washed, and resuspended in the same
volume of BHI with 5 M CdCl2 and without D-serine. The cells were then
incubated for 15 min at room temperature to allow the incorporation of D-ala-
nine into the cell wall and then labeled with a mixture of equal amounts of
vancomycin (Sigma) and a Bodipy FL conjugate of vancomycin (Van-FL; Mo-
lecular Probes) at a final concentration of 1 g/ml for 5 min at room temperature
with agitation. Cells were then analyzed by fluorescence microscopy using a Zeiss
Axiovert inverted microscope.
Mouse lung infection. For mouse lung infection, S. aureus strain LAC
(USA300) was cultured aerobically on blood agar at 37°C overnight and then in
5 ml of CCY medium.
Animal experiments were carried out with 6-week-old female BALB/c mice
(Harlan, Indianapolis, IN), in accordance with National Institutes of Health
guidelines, and were approved by the Institutional Animal Care and Use Com-
mittee at the Texas A&M HSC Institute of Biosciences and Technology. Lung
infections were induced with 5  107 S. aureus cells in a volume of 20 l
administered intranasally as previously described (37). Six hours after infection,
mice were treated intramuscularly with either imipenem at 25 mg/kg of body
weight, cefoxitin at 150 mg/kg, or phosphate-buffered saline (PBS). Injections
were repeated every 12 h, and mice were sacrificed after 3 days. Lung samples
were homogenized in Trizol (Sigma-Aldrich) and processed in a MagNA Lyser
system (Roche), and then total RNA was extracted using a MagNA Pure LC
RNA isolation kit (Roche) as recommended by the provider. Total RNA yield
was measured by a NanoDrop spectrophotometer, and 1 g of total RNA was
reverse transcribed using a Promega reverse transcription system with specific
gyrB and pvl reverse primers (Table 2). The resulting cDNA was used as a
template for real-time amplification (LightCycler 2.0 Roche) with gyrB and pvl
primers. Furthermore, pvl-specific transcripts were normalized with respect to
the gyrB transcription level, and pvl expression levels in mice treated with either
imipenem or cefoxitin were expressed as n-fold differences relative to pvl expres-
sion levels in animals treated with PBS. RT-PCR experiments were conducted
in triplicate on lung samples from five different mice treated with imipenem,
cefoxitin, or PBS.
Statistical analysis. Statistical analyses were based on the use of one-way
analysis of variance (ANOVA) followed by a posteriori Dunnett’s test. The level
of statistical significance was set at 0.05. The tests were carried out with SPSS for
Windows, version 12.0, software.
RESULTS
MICs of beta-lactams. MICs of several beta-lactams, i.e.,
oxacillin, imipenem, cefotaxime, cefaclore, and cefoxitin, were
determined following CLSI recommendations. Results ob-
tained with CA-MRSA isolates and with LUG855 are summa-
rized in Table 3. All derivatives of LUG855 shown in Table 1
displayed similar susceptibilities to imipenem, with a MIC of
0.03 g/ml (not shown).
Effects of beta-lactams on PVL production by CA-MRSA
strains. To examine the influence of beta-lactams on PVL
TABLE 2. Primers used for qPCR on LightCycler
Primer Sequence (5–3) Reference
gyrB F GGTGGCGACTTTGATCTAGC 37
gyrB R TTATACAACGGTGGCTGTGC 37
pbp1 F AGGTAGCGGTTTTGTGTCC This work
pbp1 R TATCCTTGTCAGTTTTACTGTC This work
pbp1phi GATTATCTATCTGTTTAGGATCC This work
pbp2 F TATTTAGCCGGTTTACCTCA This work
pbp2 R TTTTGACGTTCTTCAGGAGT This work
pbp3 F GTGGACCAACCTCATCTTTA This work
pbp3 R CGGGAGACCCTTATTATTCT This work
pbp4 F TGGTGCTAACTGCTTTGTAA This work
pbp4 R GCTAAAGCTATCGGAATGAA This work
lukS-PV F AATAACGTATGGCAGAAATATGGATGT This work
lukS-PV R CAAATGCGTTGTGTATTCTAGATCCT This work
ISPVL1 CTAATTGTTCTTTAACTTGAATTAAGTTTGACC This work
ISPVL2 TGTTAAGAACATGAAGCCTTTGATTGT This work
RNA III F GGGATGGCTTAATAACTCATAC This work
RNA III R GGAAGGAGTGATTTCAATGG This work
sarA F TGTTTGCTTCAGTGATTCGT This work
sarA R CAGCGAAAACAAAGAGAAAG This work
saeR F CGTGGATGATGAACAAGACA This work
saeR R TTCACGGTATTAGCATCTTCG This work
rot F GGGATTGTTGGGATGTTTGTTA This work
rot R CATTGCTGTTGCTCTACTTGC This work
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release, PVL in culture supernatants was quantified for 4 clin-
ical CA-MRSA strains incubated with 1/4 the MIC of oxacillin,
imipenem, cefotaxime, cefaclore, or cefoxitin for 6 h. As shown
in Fig. 1, the effects were different from one beta-lactam to
another. In the presence of oxacillin, all 4 strains displayed
increased PVL production. The increases were strain depen-
dent and ranged from 2.10- to 6.12-fold higher than the growth
control level. We obtained similar results with imipenem,
which led to increased PVL production for all 4 strains, rang-
ing from 2.5 to 6.5 times the growth control level. The three
other beta-lactams tested, cefotaxime, cefaclore, and cefoxitin,
did not modify the PVL production of any of the 4 CA-MRSA
strains.
Effects of beta-lactams on PVL expression by LUG855. We
used the laboratory strain LUG855 to further examine the
effects of subinhibitory concentrations of beta-lactams (1/4 the
MIC) on PVL expression. We performed PVL-specific ELISA
quantification with the supernatants of 6-h cultures and ob-
served that oxacillin and imipenem increased PVL expression
2.25- and 3.4-fold compared to the growth control level, while
cefotaxime, cefaclore, and cefoxitin did not increase the PVL
level compared to the no-antibiotic control level (Fig. 1). PVL-
specific relative qRT-PCR performed on the cellular pellets
yielded similar results: cultures treated with oxacillin and imi-
penem displayed increased PVL mRNA levels (17.3- and 22.5-
fold, respectively), while cefotaxime, cefaclore, and cefoxitin
did not modify the PVL mRNA level. To rule out a possible
excision of the phage in response to stress-induced antibiotics,
the copy number of the pvl gene was analyzed by qPCR and
showed no variation, regardless of the beta-lactam added (Fig.
2). This result was confirmed by the absence of detectable
newly formed attP insertion sites of phiPVL phage as mea-
sured by specific qPCR (results not shown).
Effects of beta-lactams on PBP1 expression by LUG855.
Penicillin-binding protein 1 (PBP1) is supposed to be the com-
mon target of oxacillin and imipenem (68) but not of cefo-
taxime, cefaclore, and cefoxitin (17, 27, 28). Binding of beta-
lactams to PBP1 results in subsequent PBP1 dysfunction,
leading to mechanically weak peptidoglycan, which bacteria
may tend to compensate by enhanced pbp1 gene transcription.
We performed qRT-PCR with PBP1-specific primers (Table
2) on the cellular pellets and detected a significantly increased
TABLE 3. MICs of selected antibiotics for methicillin-susceptible
S. aureus and CA-MRSA isolates in CCY broth
Strain
MIC (g/ml)
Oxacillin Imipenem Cefotaxime Cefaclore Cefoxitin
HT20010734 16 8 4 16 256
HT20020488 8 8 2 16 128
HT20030203 16 8 8 64 256
HT20041010 16 2 2 64 128
LUG855 0.06 0.03 0.5 2 0.5
FIG. 1. Effects of beta-lactams on PVL expression. S. aureus strains
HT20010734, HT20030203, HT20041010, HT20020488, and LUG855
were grown in CCY medium at 37°C with gyratory shaking (300 rpm)
in the absence (growth control) and presence of different antibiotics at
1/4 the MIC. After 6 h of incubation, aliquots of cultures were adjusted
to an OD600 of 1 and then centrifuged at 13,000  g for 10 min. PVL
in supernatants was quantified by ELISA. Results are ratios of g of
PVL/ml of adjusted culture incubated with the indicated antibiotic to
means of g of PVL/ml of adjusted culture incubated without antibi-
otic and are expressed as percentages. Values are means  standard
deviations (four different doubled experiments). *, statistically differ-
ent from the control (corresponding isolate grown without antibiotic),
with a P value of 	0.05, by one-way analysis of variance followed by a
posteriori Dunnett’s test.
FIG. 2. Effects of beta-lactams on PVL expression and pvl gene
copy number. S. aureus LUG855 cultures were performed as described
in the legend to Fig. 1. After 6 h of incubation, aliquots of the same
cultures were used for either total RNA or genomic DNA extraction as
described in Materials and Methods. The RNA yielded was used for
subsequent reverse transcription with random primers, as described in
the text, and the cDNA obtained was used as a template for Light-
Cycler PCR with pvl-specific primers (Table 2). Relative quantification
was performed by normalization to gyrB expression as described else-
where (37). Results are expressed as n-fold differences of luk-PV
(black bars) mRNA levels detected in the presence of different anti-
biotics relative to the PVL mRNA level of the strain grown without
antibiotics. Genomic DNA was used as a template for real-time pvl and
gyrB PCRs using specific primers (Table 2). Relative quantification of
the pvl gene copy number was assessed after normalization to the gyrB
copy number. Results are expressed as n-fold variations of the pvl/gyrB
copy number (gray bars) in the presence of antibiotics relative to the
pvl/gyrB copy number of the growth control. Values are means 
standard deviations (three different experiments).
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PBP1 mRNA level (4.5-fold) when cultures were treated with
imipenem and a slightly increased PBP1 mRNA level (2.3-
fold) when cultures were treated with oxacillin (Fig. 3). We
also performed qRT-PCR with PBP2-, PBP3-, and PBP4-spe-
cific primers (Table 2) in order to study the effects on PBP2 to
-4 expression upon exposure to imipenem and oxacillin (Fig.
3). As expected, imipenem (high-affinity ligand of PBP1 [68])
modified only the PBP1 mRNA level, while oxacillin (nonse-
lective PBP ligand) increased PBP1 and PBP2 mRNA levels
and, to a lesser extent, PBP3 mRNA levels. Therefore, we
concluded that the common bacterial target of oxacillin and
imipenem is PBP1. We did not detect increased PBP1 mRNA
levels in cultures treated with cefotaxime, cefaclore, or cefoxi-
tin (results not shown).
Effect of antisense RNA depletion of pbp1 on PVL expres-
sion. Since oxacillin and imipenem are the two beta-lactams
increasing PVL expression and also interfering with PBP1, we
hypothesized that PBP1 dysfunction could somewhat lead to
augmentation of PVL. We investigated this hypothesis by re-
ducing pbp1 expression by use of a cadmium-inducible cassette
that expresses antisense pbp1 RNA (Fig. 4A). Since PBP1 was
shown to be an essential enzyme involved in septum formation
(51), we checked for cadmium-induced PBP1 depletion by
observing fluorescence microscopy images of LUG1477 and
LUG1485 (negative control) stained with Van-FL specifically
binding to the nascent division septum (Fig. 4B). Cadmium-
treated LUG1485 cultures displayed complete septa at the
normal equatorial position, resulting in tetrads and octets of
normally sized daughter cells. Cadmium-treated LUG1477 cul-
tures displayed abnormal septa with asymmetric polar local-
ization, leading to tetrads and octets of cocci accumulating
without respect to the normal alternating perpendicular
planes.
Strain LUG1477 harboring pLUG792 and its control,
LUG1485 harboring pLUG795 (derived from pLUG792 but
lacking the pbp1 antisense fragment), were cultured for 6 h in
the presence of different cadmium concentrations (ranging
from 0 to 5 M). qRT-PCR was performed on the cellular
pellets to detect PVL expression and antisense pbp1 RNA
expression (with primers pbp1R and pbp1phi [Table 2]). As
shown in Fig. 5, we observed dose-dependent inductions of
antisense pbp1 RNA and luk-PV mRNA with CdCl2 at 0 to 5
M. Thus, at 2.5 M CdCl2, antisense pbp1 RNA increased
120-fold, while PVL mRNA increased 5.4-fold. The biggest
increases were observed with 5 M CdCl2, with increases of
166-fold for antisense pbp1 RNA and 18.5-fold for PVL
mRNA. Higher levels of CdCl2 were inhibitory to growth.
Bacterial counts of viable cells were performed for LUG1477
cultures by dilution and plating, which yielded 5 108 CFU/ml
for LUG1477 cultured without Cd and 1.8  108 CFU/ml for
LUG1477 cultured with 5 M CdCl2.
Similar experiments were performed with the control strain
FIG. 3. Effects of oxacillin and imipenem on PBP1 to -4 expression.
S. aureus LUG855 cultures with either imipenem or oxacillin were
performed as described in the legend to Fig. 1. After 6 h of incubation,
aliquots were used for total RNA extraction and subsequent reverse
transcription with random primers, as described in the text, and the
cDNA obtained was used as a template for LightCycler PCRs with
pbp1- to -4-specific primers (Table 2). Relative quantification was
performed by normalization to gyrB expression as described elsewhere
(37). Results are expressed as n-fold differences of pbp1 (gray bars),
pbp2 (black bars), pbp3 (white bars), and pbp4 (hatched bars) mRNA
levels detected in the presence of different antibiotics relative to PBP1
to -4 mRNA expression of the strain grown without antibiotics. Values
are means  standard deviations (three different experiments).
Changes in mRNA levels were interpreted as significant if they were
2-fold.
FIG. 4. (A) Map of pLUG792 plasmid. pLUG792 is a derivative of
the S. aureus expression vector pCN37 which employs a cadmium-
inducible promoter (Pcad) with the cadmium regulator (cadR) to ex-
press a specific 265-nucleotide PBP1 antisense RNA cloned upstream
of the pvl terminator. The plasmid contains a staphylococcal pT181
replicon and a colE1 replicon, as well as erythromycin resistance
(ermC) and ampicillin resistance (ampR) genes. (B) Fluorescence mi-
croscopy images of LUG1485 and LUG1477 stained with Van-FL
specifically binding to the nascent division septum. Cd-treated
LUG1485 cultures displayed complete septa at the normal equatorial
position, resulting in tetrads and octets of normally sized daughter
cells. Cd-treated LUG1477 cultures displayed abnormal septa with
asymmetric polar localization, leading to tetrads and octets of cocci
accumulating without respect to the normal alternating perpendicular
planes.
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LUG1485, which showed no increase of luk-PV mRNA expres-
sion at any CdCl2 concentration tested (results not shown).
Effects of major S. aureus regulators on PVL expression and
on PVL induction by imipenem. PVL expression is known to be
modulated by several global virulence regulators of S. aureus
(7, 67). We therefore investigated the impacts of agr, saeRS,
rot, and sarA deletions on PVL induction by imipenem to find
out whether one of these regulators was a potential mediator
of the inductive effect of beta-lactams on PVL expression. We
used isogenic S. aureus strains belonging to the same genetic
background (RN6390) and deleted for one of each of the
major regulators investigated. Isogenic pairs (parental strain
and mutant of interest) were cultured for 6 h with 1/4 the MIC
of imipenem as described above, and PVL production was
measured in the supernatants, while cellular pellets were as-
sayed for luk-PV mRNA expression by qRT-PCR.
As shown in Fig. 6A and B and 7A and B, agr and sae are
powerful positive regulators of PVL expression, as their dele-
tion led to dramatically decreased PVL expression, with a
48-fold decrease of the luk-PV mRNA level in the 
agr strain
and an 18.7-fold decrease of the luk-PV mRNA level in the

saeRS strain (Fig. 7A and B). PVL quantification in the
supernatant yielded a 10-fold decrease of PVL production in
the 
agr strain and a 15-fold decrease of PVL production in
the 
saeRS strain (Fig. 7A and B). Nevertheless, when they
were cultured with imipenem, both the agr- and saeRS-deleted
strains displayed increased PVL expression, although the
range of increased expression was reduced in comparison with
the range obtained with the parental strains.
FIG. 5. Effect of PBP1 depletion by antisense mechanism on PVL
expression. Strain LUG1477 (containing pLUG792) was cultured at
37°C with vigorous shaking in CCY broth supplemented with increas-
ing concentrations of CdCl2 (0, 1, 2.5, and 5 M). After 6 h of incu-
bation, aliquots of cultures were washed, adjusted to an OD600 of 1,
and then used for total RNA extraction and subsequent reverse tran-
scription with random primers as described in Materials and Methods.
The cDNA obtained was used as a template for LightCycler PCRs with
specific pvl primers and specific pbp1 antisense primers pbp1R and
pbp1phi, which encompass the junction between the pbp1 antisense
fragment and the pvl terminator. Relative quantification was per-
formed by normalization to gyrB expression as described elsewhere
(37). Results are expressed as n-fold differences of luk-PV mRNA
(bars) or antisense pbp1 RNA (diamonds) levels detected in the pres-
ence of different CdCl2 concentrations relative to the luk-PV mRNA
or antisense pbp1 RNA expression level of the strain grown without
CdCl2. Values are means  standard deviations (three different ex-
periments).
FIG. 6. Effects of imipenem (IMI) on PVL production by isogenic strains deleted for agr (A), saeRS (B), rot (C), and sarA (D). Cultures were
performed in CCY medium at 37°C with gyratory shaking (300 rpm) in the absence (growth control; white bars) and presence of imipenem at 1/4
the MIC (gray bars). After 6 h of incubation, aliquots of cultures were adjusted to an OD600 of 1 and then centrifuged at 13,000  g for 10 min.
PVL in supernatants was quantified by ELISA, and results are expressed as g of PVL/ml. Values are means  standard deviations (four different
doubled experiments). *, statistically different from the control (corresponding isolate grown without antibiotic), with a P value of 	0.05, by
one-way analysis of variance followed by a posteriori Dunnett’s test.
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Rot deletion resulted in slightly increased PVL production
(1.5-fold), along with an 8.4-fold increase in the luk-PV mRNA
level. As shown in Fig. 6C and 7C, imipenem incubation of the

rot strain yielded neither increased PVL production nor an
enhanced luk-PV mRNA level, suggesting that rot deletion
interferes with the inducing effect of imipenem on PVL ex-
pression. The inductive effect of imipenem was restored by rot
complementation with a low-copy-number plasmid. When it
was cultured with imipenem, the rot-complemented strain
showed a 2.2-fold increase of PVL production and an 8.8-fold
enhancement of the luk-PV mRNA level (Fig. 6C and 7C).
In contrast to the case with rot, sarA deletion resulted in
decreased PVL production (3.6-fold), along with a 7.2-fold
decrease in the luk-PV mRNA level. As shown in Fig. 6D and
7D, imipenem incubation of the 
sarA strain yielded neither
increased PVL production nor an enhanced luk-PV mRNA
level, suggesting that the absence of SarA also interferes with
the inductive effect of imipenem on PVL expression. To con-
firm this hypothesis, the inducing effect of imipenem was re-
stored by chromosomal sarA complementation. When it was
cultured with imipenem, the sarA-complemented strain
showed a 2.1-fold increase of PVL production and a 4-fold
enhanced luk-PV mRNA level.
Modulator effect of imipenem on expression of major S.
aureus regulators. By using a laboratory strain and three clin-
ical strains belonging to three major CA-MRSA lineages (ST1,
ST8, and ST80), we investigated a possible modulation of vir-
ulence regulators of S. aureus by subinhibitory concentrations
of imipenem. Since our results suggest that rot and sarA are
global regulators involved in the induction of PVL expression
by imipenem, we performed qRT-PCR to assay for direct mod-
ulation of rot and sarA expression in S. aureus cultured with
imipenem. Accordingly, qRT-PCR was performed with specific
primers for RNAIII (the major transcript of the agr operon),
saeR, sarA, and rot (Table 2) on aliquots removed after 30 min
and hourly from LUG855, HT20030203, HT20020488, and
HT20010734, cultured with and without imipenem at 1/2 the
MIC. The mRNA levels of the 4 regulators in the presence of
antibiotic were compared to the mRNA levels expressed with-
out antibiotics. As shown in Fig. 8, after 30 min of incubation
with imipenem, we observed increased SarA mRNA levels for
all strains tested, ranging from 4.6- to 8.9-fold compared to the
FIG. 7. Effects of imipenem on luk-PV mRNA expression by isogenic strains deleted for agr (A), saeRS (B), rot (C), and sarA (D). Cultures
were performed in CCY medium at 37°C with gyratory shaking (300 rpm) in the absence (growth control; white bars) and presence of imipenem
at 1/4 the MIC (gray bars). After 6 h of incubation, aliquots of cultures were adjusted to an OD600 of 1 and then used for total RNA extraction
and subsequent reverse transcription with random primers as described in Materials and Methods. The cDNA obtained was used as a template
for LightCycler PCRs with specific pvl and gyrB primers. Relative quantification was performed by normalization to gyrB expression as described
elsewhere (37). Results are expressed as n-fold differences of luk-PV mRNA levels relative to the PVL transcript level from the wild-type parental
strain (LUG855, LUG1053, or LUG1436) grown without imipenem. Values are means  standard deviations (three different experiments).
Changes in mRNA levels were interpreted as significant if they were 2-fold.
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growth control levels. As assessed by qRT-PCR, the expression
levels of RNAIII, saeR, and rot were not modified after 30 min
of incubation with imipenem for any strain tested. Further-
more, after 1 h of incubation with imipenem, we observed
increased sarA mRNA levels for LUG855 (4.5-fold) and
HT20020488 (2.9-fold) and decreased rot mRNA levels for
HT20030203 (5.9-fold) and HT20010734 (12-fold). Significant
decreases in the rot mRNA level were detected for all strains,
ranging from 7.7- to 25-fold and from 4.5- to 27-fold after 2 and
3 h, respectively, compared to the growth control level. After
4 h of incubation with imipenem, we detected decreased rot
mRNA levels only for the three clinical strains: a 12-fold de-
crease in HT20030203, a 12.4-fold decrease in HT20020488,
and a 2.7-fold decrease in HT20010734. After 5 h of incubation
with imipenem, no variation in the expression of any of the 4
regulators investigated was detected, regardless of the strain.
Nevertheless, starting with 4 h of incubation, we observed
significant increases of the PVL mRNA level in the presence of
imipenem for all strains tested, ranging from 2.4- to 6.6-fold at
4 h and from 6.5- to 11.5-fold at 5 h. The same experiment was
performed with another beta-lactam as a control (cefoxitin at
1/2 the MIC). We observed no variation in the expression of
any of the 4 regulators investigated, nor did we detect in-
creased PVL mRNA expression after cefoxitin treatment (re-
sults not shown).
Effects of beta-lactams on PVL mRNA expression in mouse
lung infection. To examine the influence of beta-lactams at
subinhibitory concentrations on PVL expression in vivo, mice
were challenged intranasally with CA-MRSA strain LAC
(USA300). Six hours after infection, mice were treated twice
daily with either imipenem, cefoxitin, or no antibiotic (10 to 12
mice per group) and then sacrificed at day 3. PVL expression
in lung tissues was detected only in tissues where CFU counts
of recovered bacteria were 5 log per gram of tissue, corre-
sponding to 5 animals per group. For these samples, pvl-spe-
cific transcripts were normalized with respect to the gyrB tran-
scription level, and pvl expression levels in mice treated with
either imipenem or cefoxitin were expressed as n-fold differ-
ences relative to the pvl expression level in untreated animals.
As shown in Fig. 9, the PVL mRNA level detected in imi-
penem-treated mice was 6.7 times higher than the PVL mRNA
level observed in PBS-treated mice. There was no modification
FIG. 8. Effects of imipenem on agr, sae, rot, and sarA mRNA ex-
pression. S. aureus strains LUG855, HT20030203, HT20020488, and
HT20010734 were cultured without antibiotics as described above and
monitored for OD; when the OD600 reached 0.5, imipenem was added
to the culture at 1/2 the MIC and cultures were reincubated at 37°C
with gyratory shaking (300 rpm). Aliquots were taken every hour, and
cellular pellets were prepared as described before for total RNA ex-
traction and subsequent reverse transcription with random primers.
The cDNA obtained was used as a template for LightCycler PCRs with
gyrB-, RNA III-, saeR-, rot-, sarA-, and pvl-specific primers. Relative
quantification was performed by normalization to gyrB expression as
described elsewhere (37). Results are expressed as n-fold differences of
RNAIII (black bars), sae (white bars), sarA (hatched bars), rot (gray
bars), and pvl (horizontally striped bars) mRNA levels detected in the
presence of imipenem relative to the mRNA expression of the strain
grown without antibiotics for different times (30 min to 5 h). Values
are means  standard deviations (three different experiments).
Changes in mRNA levels were interpreted as significant if they were
2-fold.
FIG. 9. Effects of beta-lactams on PVL expression in vivo. Six-
week-old female BALB/c mice were challenged intranasally with 5 
107 S. aureus CA-MRSA LAC (USA300) organisms as previously
described (37). Six hours after infection, mice were treated twice daily
with either imipenem, cefoxitin, or PBS. Mice were sacrificed after 3
days, and lung samples were assessed for PVL mRNA expression as
described above. PVL-specific transcripts were normalized with re-
spect to the gyrB transcription level, and pvl expression levels in mice
treated with either imipenem or cefoxitin were expressed as n-fold
differences relative to the pvl expression level in animals treated with
PBS. Values are means  standard deviations. Experiments were con-
ducted in triplicate with lung samples from five different mice treated
with imipenem, cefoxitin, or PBS. Changes in mRNA levels were
interpreted as significant if they were 2-fold.
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of pvl transcripts in mice treated with cefoxitin compared to
untreated mice.
DISCUSSION
We have shown in several previous reports that oxacillin, a
major antistaphylococcal beta-lactam, increases PVL expres-
sion by inducing the pvl promoter (23). Similar observations
have been reported for other virulence determinants of S.
aureus, such as alpha-toxin (48), staphylococcal toxic shock
syndrome toxin 1 (TSST-1) (57), and the ability to bind to
fibronectin (54), thus supporting the hypothesis that subinhibi-
tory concentrations of beta-lactams enhance the overall viru-
lence of S. aureus through a so far uncharacterized signaling
pathway. Moreover, PVL is associated with intense necrosis in
vivo, probably leading to poor antibiotic diffusion and subin-
hibitory concentrations at sites of infection (10). Based on
these in vitro data, the current guidelines for management of
PVL-producing S. aureus infections restrain the use of beta-
lactams alone for treatment to avoid the potential inductor
effect on PVL expression (32). Therefore, we addressed the
question of the effect of subinhibitory beta-lactam concentra-
tions on PVL expression in vivo. Furthermore, we investigated
the mechanisms underlying PVL induction by beta-lactams in
vitro and identified cross points between the beta-lactam-trig-
gered bacterial response and the regulatory network control-
ling virulence expression in S. aureus.
By using a mouse model of CA-MRSA pneumonia, we pro-
vide for the first time in vivo data supporting the hypothesis
that some beta-lactams, such as imipenem, may promote PVL
mRNA expression in infected tissues. However, we were un-
able to measure larger amounts of PVL in the lungs of imi-
penem-treated mice, as our ELISA was not sensitive enough in
this setting (results not shown). Nevertheless, the increased
expression of PVL in our mouse model was not followed by
increased morbidity as assessed by weight loss data (results not
shown). Recently, it was emphasized that mouse polymorpho-
nuclear leukocytes (PMNs) are relatively resistant to PVL,
while human and rabbit PMNs are susceptible to its cytotoxic
effects, which could explain the absence of increased morbidity
in the mouse setting despite an increased expression of PVL
(20). Therefore, similar experiments should be conducted in
rabbits in order to address the question of whether larger
amounts of PVL achieved during beta-lactam treatment would
impact the outcome.
Beta-lactam antibiotics initiate bacterial cell death subse-
quent to their interaction with transmembrane PBPs. In wild-
type S. aureus, four PBPs have been detected (58), of which
PBPs 1 and 2 are essential. We measured PVL production of
4 CA-MRSA strains and one laboratory strain in the presence
of subinhibitory concentrations of 5 carefully selected beta-
lactams: oxacillin (a nonselective beta-lactam), imipenem
(PBP1 selective) (68), cefotaxime (PBP2 selective) (27), cefa-
clore (PBP3 selective) (28), and cefoxitin (PBP4 selective)
(17). When cultures were treated with either oxacillin or imi-
penem (PBP1 selective), but not with cefotaxime, cefaclore, or
cefoxitin, PVL production in the culture supernatant and the
luk-PV mRNA level increased concomitantly, suggesting that
PBP1 interference would be a trigger for PVL induction by
beta-lactams. We tested this hypothesis by altering PBP1 func-
tion with an inducible PBP1-specific antisense RNA and ob-
served a dose-dependent relationship between the pbp1 anti-
sense RNA level and the luk-PV mRNA level, thus confirming
that PBP1 depletion may lead to enhanced PVL expression by
S. aureus. Recent reports from Pereira et al. (50, 51) under-
lined the major role of PBP1 in the formation of the division
septum and the separation of daughter cells at the end of cell
division, probably in conjunction with the autolytic system. In
E. coli, beta-lactam inactivation of PBP3, an orthologue of S.
aureus PBP1 also involved in peptidoglycan synthesis during
cell division, induced the SOS-promoting recA and lexA genes
(44). Recently, it was shown that beta-lactams induce the SOS
response in S. aureus and promote genetic mobile element
replication and transfer in a recA- and lexA-dependent manner,
potentially resulting in the dissemination of virulence factors
harbored by temperate phages (39). Wirtz et al. obtained recA-
dependent PVL-encoding phage induction by using mitomycin
C (67). They observed increased luk-PV mRNA levels mirror-
ing the increased phage copy number due to phage replication.
One hypothesis explaining PBP1-mediated PVL induction in S.
aureus would thus be related to PVL-encoding phage induction
promoted by an SOS response. Nevertheless, quantitative PCR
assays of S. aureus depleted of PBP1 by both antibiotics and
antisense pbp1 RNA did not indicate PVL phage replication
(Fig. 2), thus arguing against the SOS-based hypothesis.
Furthermore, we investigated the possible implication of
major virulence regulators of S. aureus in PVL modulation by
PBP1-interfering beta-lactams such as imipenem. Positive reg-
ulation of PVL transcription by the agr, saeRS, and sarA loci
has already been reported (8, 67). Another SarA homologue,
Rot (repressor of toxin), downregulates hla and the gamma-
hemolysin genes (hlgB and hlgC) (55) by interacting with the
promoter regions of target genes during the exponential
growth phase. During post-exponential-phase growth, the level
of rot mRNA is repressed by agr RNAIII via an antisense
mechanism (6).
By using isogenic S. aureus strains deleted for each one of
the agr, saeRS, rot, and sarA loci, we investigated the impact of
the absence of these regulators on PVL induction by subin-
hibitory concentrations of imipenem. To determine whether
one of these regulators was essential and therefore would be a
potential mediator of the induction effect of beta-lactams on
PVL expression, we confirmed several previous reports show-
ing that agr and saeRS are powerful positive regulators of PVL
expression (8, 67). However, agr and sae were not considered
essential for PVL induction by beta-lactams, as PVL induction
by imipenem still occurred in their absence. This observation
seems contradictory to a recent report from Kuroda et al.
showing that subinhibitory concentrations of beta-lactams in-
duce hla expression in S. aureus through the saeRS system (36).
This difference in observation could be attributed to strain
variations. Nevertheless, since in that work the inductor used
was not imipenem but cefoxitin, which is a PBP4-selective
beta-lactam (17), we may hypothesize that a different signaling
pathway was triggered to explain the different modulator pro-
file.
In contrast, SarA and its homologue Rot are probably es-
sential for PVL induction by imipenem (Fig. 5 and 6). PVL
expression in sarA- and rot-inactivated strains was not modified
by imipenem, while the inducing effect of imipenem on PVL
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expression was restored in the complemented strains. The pos-
itive regulatory effect of SarA on PVL expression has already
been reported (8); here we report for the first time the negative
regulator role of rot in PVL expression, consistent with several
previous observations of rot as a downregulator of exoprotein
expression (55).
Kinetic measures of the regulator transcription level during
CA-MRSA incubation with subinhibitory concentrations of
imipenem suggest that sarA expression is triggered first, by a so
far unknown signal, and then rot is downregulated, with both
modifications resulting in enhanced PVL expression. Our re-
sults do not clarify whether downregulation of rot occurs inde-
pendently or is a subsequent effect of SarA overexpression.
Although the mechanism is still not clearly established, Manna
and Ray (42) reported experiments indicating that SarA is
involved in negative regulation of rot transcription, suggesting
that rot downregulation during imipenem treatment may be a
consequence of enhanced SarA expression. Utaida et al. re-
ported neither sarA nor rot modulation in their genomewide
transcriptional profile of S. aureus 8325-4 upon oxacillin treat-
ment (63). However, they performed their assay after 1 h of
culture in the presence of 5 to 10 times the MIC of oxacillin,
while we performed our assay after 30 min to 5 h of culture
with 1/2 the MIC of imipenem. Therefore, these different ob-
servations may not be held as contradictory.
We were surprised to observe a 3-h delay between the acti-
vation of sarA and luk-PV induction. Stevens et al. reported a
delayed inductor effect of subinhibitory concentrations of naf-
cillin on PVL expression (57). They detected increased PVL
mRNA levels starting 4 h and up to 34 h after nafcillin treat-
ment. Altogether, these data suggest that the beta-lactam in-
ductor effect on PVL and the mechanisms involved may be
dependent on the growth phase and promoted during the post-
exponential phase. This hypothesis is also consistent with the
fact that SarA is involved in negative regulation of rot tran-
scription mainly during the postexponential phase of growth
(42).
Taken together, these data suggest that at subinhibitory con-
centrations, beta-lactams which bind to and inactivate PBP1,
such as imipenem and oxacillin, trigger SarA by a so far un-
characterized pathway and increase SarA expression, which
subsequently downregulates Rot expression, thus leading to
enhanced PVL expression. Although the link between PBP1
inactivation and sarA triggering has never been put forward, it
may be related to the essential role performed by PBP1 during
septum formation and cell division. PBP1 inactivation results
in a dramatic inhibition of autolysis and a rapid decline in
transcription of most autolytic enzymes, especially at the atl
locus (50), thus preventing bacterial death. SarA was shown to
be a negative regulator of atl expression and necessary for
bacterial survival during penicillin-induced killing (25); there-
fore, it may be involved in autolysis repression by beta-lactams.
In this respect, SarA modulation could be the consequence of
an adaptation mechanism allowing bacterial persistence in the
presence of imipenem. Another argument supporting the role
of autolytic signals in the beta-lactam-induced regulatory path-
way is that proteomic analysis of S. aureus undergoing in-
creased autolysis triggered by Triton X-100 also resulted in
increased SarA levels, coupled with a significant reduction in
the Rot level (16).
We propose—as a working hypothesis—that the alterations
in the composition of peptidoglycan caused by PBP1 dysfunc-
tion generate a signal processed by a transduction pathway that
controls the expression of autolytic genes, resulting in the in-
hibition of the activity of the autolytic system and promoting
bacterial survival. The existence of complex regulatory circuits
coupling the autolytic system to cell wall synthesis, possibly
involving the SarA regulator, remains to be explored. This
should provide a link between cell wall turnover control and
virulence regulation in S. aureus, suggesting that enhanced
virulence may be promoted during beta-lactam-induced bacte-
rial persistence. Therefore, our results could explain the trend
toward increasing resistance and virulence of PVL-producing
S. aureus and may also promote appropriate treatment guid-
ance to combat PVL-related infections.
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